1. Home
  2. TRVI vs LOCO Comparison

TRVI vs LOCO Comparison

Compare TRVI & LOCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRVI
  • LOCO
  • Stock Information
  • Founded
  • TRVI 2011
  • LOCO 1980
  • Country
  • TRVI United States
  • LOCO United States
  • Employees
  • TRVI N/A
  • LOCO N/A
  • Industry
  • TRVI Biotechnology: Pharmaceutical Preparations
  • LOCO Restaurants
  • Sector
  • TRVI Health Care
  • LOCO Consumer Discretionary
  • Exchange
  • TRVI Nasdaq
  • LOCO Nasdaq
  • Market Cap
  • TRVI 363.7M
  • LOCO 354.1M
  • IPO Year
  • TRVI 2019
  • LOCO 2014
  • Fundamental
  • Price
  • TRVI $4.60
  • LOCO $11.83
  • Analyst Decision
  • TRVI Strong Buy
  • LOCO Hold
  • Analyst Count
  • TRVI 8
  • LOCO 2
  • Target Price
  • TRVI $9.31
  • LOCO $13.00
  • AVG Volume (30 Days)
  • TRVI 739.7K
  • LOCO 184.2K
  • Earning Date
  • TRVI 03-19-2025
  • LOCO 03-06-2025
  • Dividend Yield
  • TRVI N/A
  • LOCO N/A
  • EPS Growth
  • TRVI N/A
  • LOCO 0.40
  • EPS
  • TRVI N/A
  • LOCO 0.78
  • Revenue
  • TRVI N/A
  • LOCO $470,971,000.00
  • Revenue This Year
  • TRVI N/A
  • LOCO $2.70
  • Revenue Next Year
  • TRVI N/A
  • LOCO $4.25
  • P/E Ratio
  • TRVI N/A
  • LOCO $15.13
  • Revenue Growth
  • TRVI N/A
  • LOCO N/A
  • 52 Week Low
  • TRVI $2.30
  • LOCO $8.17
  • 52 Week High
  • TRVI $5.05
  • LOCO $14.25
  • Technical
  • Relative Strength Index (RSI)
  • TRVI 62.80
  • LOCO 44.17
  • Support Level
  • TRVI $3.93
  • LOCO $12.26
  • Resistance Level
  • TRVI $4.14
  • LOCO $12.65
  • Average True Range (ATR)
  • TRVI 0.29
  • LOCO 0.35
  • MACD
  • TRVI 0.06
  • LOCO -0.01
  • Stochastic Oscillator
  • TRVI 64.82
  • LOCO 27.24

About TRVI Trevi Therapeutics Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.

About LOCO El Pollo Loco Holdings Inc.

El Pollo Loco Holdings Inc operates and franchises hundreds of fast-casual chicken restaurants in the United States. Restaurant locations are typically free-standing and include drive-thrus, and menus include many low-priced options. Poultry is the company's largest food cost, accounting for roughly 38% of total food and paper cost, and the company manages that commodity price risk by using multiple suppliers and entering supply contracts of varying lengths depending on market conditions.

Share on Social Networks: